From 1988 to Beyond: A Personal Journey Through the Promises and Perils of Regenerative Medicine.

#regenerative #medicine #bio #tech
Share

Dr. McFarland, a former administrator with the Food and Drug Administration and current Chief Regulatory Officer of ARMI, Dean Kamen’s renowned research program, will deliver "From 1988 to Beyond: A Personal Journey Through the Promises and Perils of Regenerative Medicine.

ARMI is the new and expanding Advanced Regenerative Manufacturing Instiute created here in Manchester, intended to create a global center of excellence in the local area for regenertive medicine. 



  Date and Time

  Location

  Hosts

  Registration



  • Date: 24 Jun 2019
  • Time: 01:00 PM to 03:30 PM
  • All times are (UTC-04:00) Eastern Time (US & Canada)
  • Add_To_Calendar_icon Add Event to Calendar
  • 1 Covenant Way
  • Bedford, New Hampshire
  • United States 03110
  • Building: Bethany Covenant Church
  • Click here for Map

  • Contact Event Host
  • Co-sponsored by GSC OLLI
  • Starts 08 June 2019 08:37 AM
  • Ends 24 June 2019 01:00 PM
  • All times are (UTC-04:00) Eastern Time (US & Canada)
  • No Admission Charge


  Speakers

Dr. McFarland of ARMI

Topic:

From 1988 to Beyond: A Personal Journey Through the Promises and Perils of Regenerative Medicine

Biography:

Dr. McFarland, a former administrator with the Food and Drug Administration and current Chief Regulatory Officer of ARMI, in Manchester, NH

"I joined ARMI as its Chief Regulatory Officer effective May 1, 2017. My position at ARMI will allow me to apply my knowledge and experiences gained by over the last decade and half at FDA developing risk-based policy for tissue engineering and regenerative medicine (TE/RM) products, and broader interagency efforts to create an interlocking network of interagency activities to foster growth of basic and translational science to support maturation of the TE/RM from primarily discovery science toward a stage of commercial development through ARMI’s efforts to establish an industrial commons. This industrial commons will take the form of an institute within the Manufacturing USA network, with the aims to coalesce the field and provide a route for nascent product concepts to reach the marketplace. Bringing these products to the market will benefit critical U.S. public health needs and will provide the economic drivers needed to create new highly-skilled jobs. "

Address:New Hampshire, United States